An abnormal CT, now what: issues in the diagnosis and management of a patient with a potential lung cancer Source: Annual Congress 2006 - MP11 - An abnormal CT, now what: issues in the diagnosis and management of a patient with a potential lung cancer Year: 2006
When lung cancer was rare: An historical study of prevalence from 1760 . Source: International Congress 2018 – Lung cancer: risk factors, supportive measures and quality improvement Year: 2018
A new WHO classification for lung cancer after 11 years: clinical implications Source: International Congress 2015 – Lung cancer pathology Year: 2015
A network lung cancer pathway in review: Are we choosing the right diagnostic approach? Source: Annual Congress 2010 - Quality management for lung cancer patients Year: 2010
Lung cancer survival in the UK: are the results from the national lung cancer audit (LUCADA) dependent on completeness of case reporting? Source: Annual Congress 2009 - Epidemiology and management of lung cancer Year: 2009
ERS School Course Early-stage lung cancer - What's new in the epidemiology of lung cancer: the female aspect Source: ISSN=ISSN 1810-6838, ISBN=, page=339 Year: 2006
A study of the public‘s awareness of the causation of lung cancer Source: Eur Respir J 2005; 26: Suppl. 49, 184s Year: 2005
Biomarkers for non-small cell lung cancer (NSCLC) treatment: examples and unmet needs, a clinical perspective Source: International Congress 2014 – From bench to bedside: biomarkers and biobanking for lung cancer in 2014 Year: 2014
Lung cancer: the importance of seeing a respiratory physician Source: Eur Respir J 2003; 21: 606-610 Year: 2003
COVID-19 and the management of thoracic cancer patients: challenges and recommendations Source: ERS webinar 2020: COVID-19 and the management of thoracic cancer patients: challenges and recommendations Year: 2020
Trends of the proportion of small-cell lung cancer (SCLC) over the last 20 year: a university medical center experience Source: Annual Congress 2007 - Rare tumours, risk factors and epidemiology in thoracic oncology Year: 2007
ESR/ERS statement paper on lung cancer screening Source: Guideline 2020 Year: 2020
ESR/ERS statement paper on lung cancer screening Source: Eur Respir J, 55 (2) 1900506; 10.1183/13993003.00506-2019 Year: 2020
The changing face of lung cancer: Evidence from a 14-year study Source: Eur Respir J 2003; 22: Suppl. 45, 252s Year: 2003
Treatment of extensive-stage small cell lung carcinoma: current status and future prospects Source: Eur Respir J 2010; 35: 202-215 Year: 2010
Survival outcomes in advance non-small cell lung cancer – A developing country scenario Source: Annual Congress 2011 - Quality management for lung cancer patients Year: 2011
Gemcitabine (G) or vinorelbine (V)? What's the best drug in combination with a platinium-derivative for the treatment of locally advanced and metastatic non small cell lung cancer (NSCLC)? A 6 years retrospective study Source: Eur Respir J 2003; 22: Suppl. 45, 527s Year: 2003
Close surveillance strategy for early lung cancer: results of 15 years of observation Source: Annual Congress 2008 - New trends in interventional pulmonology Year: 2008